The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice
| dc.contributor.author | Mayo, Tomás de | |
| dc.contributor.author | Conget, Paulette | |
| dc.contributor.author | Becerra-Bayona, Silvia | |
| dc.contributor.author | Sossa, Claudia L. | |
| dc.contributor.author | Galvis, Virgilio | |
| dc.contributor.author | Arango-Rodríguez, Martha | |
| dc.date.accessioned | 2019-08-20T00:41:39Z | |
| dc.date.available | 2019-08-20T00:41:39Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | Mesenchymal stromal cells (MSCs) have shown to be a promising tool in cell therapies to treat different conditions. Several pre-clinical and clinical studies have proved that the transplantation of MSCs improves wound healing. Here, we compare the beneficial effects of mouse bone marrow-derived allogeneic MSCs (allo-mBM-MSCs) and their acelullar derivatives (allo-acd-mMSCs) on skin wound healing in Non-Obese Diabetic (NOD) mice. One dose of allo-mBM-MSCs (1×106 cells) or one dose of allo-acd-mMSCs (1X) were intradermally injected around wounds in 8–10 week old female NOD mice. Wound healing was evaluated macroscopically (wound closure) every two days, and microscopically (reepithelialization, dermoepidermal junction, skin appendage regeneration, leukocyte infiltration, vascularization, granulation tissue formation, and density of collagen fibers in the dermis) after 16 days of MSC injection. In addition, we measured growth factors and specific proteins that were present in the allo-acd-mMSCs. Results showed significant differences in the wound healing kinetics of lesions that received allo-acd-mMSCs compared to lesions that received vehicle or allo-mBM-MSCs. In particular, mice treated with allo-acd-mMSCs reached significantly higher percentages of wound closure at day 4, 6 and 8, relative to the allo-mBM-MSCs and vehicle groups (p < 0.05), while wound closure percentages could not be statistically distinguished between the allo-mBM-MSCs and vehicle groups. Also, allo-acd-mMSCs had a greater influence in the skin would healing process. Specifically, they caused a less pronounced inflammatory severe response (p < 0.0001), more granulation tissue formation at an advanced stage (p < 0.0001), and higher density of collagen fibers (p < 0.05) compared to the other groups. Nevertheless, at day 16, both allo-mBM-MSCs and allo-acd-mMSCs revealed a higher effect on the recovery of the quality skin (continuous epidermis; regular dermoepidermal junction and skin appendages) relative to untreated lesions (p < 0.0001), but not between them. On the other hand, ELISA analyses indicated that the allo-acd-mMSCs contained growth factors and proteins relevant to wound healing such as IGF-1, KGF, HGF, VEGF, ANG-2, MMP-1, CoL-1 and PGE2. Compared to allo-acd-mMSCs, the administration of allo-mBM-MSCs is insufficient for wound healing in diabetic mice and delays the therapeutic effect, which maybe explained by the fact that trophic factors secreted by MSCs are critical for skin regeneration, and not the cells per se, suggesting that MSCs may require some time to secrete these factors after their administration. | |
| dc.description.version | Versión Publicada | |
| dc.format.extent | 17 p. | |
| dc.identifier.citation | PLoS ONE, 2017, 12(6) | |
| dc.identifier.uri | http://hdl.handle.net/11447/2583 | |
| dc.identifier.uri | https://doi.org/ 10.1371/journal.pone.0177533 | |
| dc.language.iso | en | |
| dc.source | Plos One | |
| dc.subject | Bone Marrow Cells/cytology | |
| dc.subject | Mesenchymal Stem Cell Transplantation | |
| dc.subject | Skin/pathology | |
| dc.subject | Cytology | |
| dc.title | The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice | |
| dc.type | Article |